よむ、つかう、まなぶ。
資料３－11―① 押谷先生・鈴木先生・西浦先生・脇田先生提出資料 (13 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000121431_00395.html |
| 出典情報 | 新型コロナウイルス感染症対策アドバイザリーボード (第110回 12／14)《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
参考文献
1.
World Health Organization. International Health Regulations (2005) Third Edition.
https://www.who.int/publications/i/item/9789241580496.
2.
World Health Organization. Pandemic influenza risk management: a WHO guide to
inform and harmonize national and international pandemic preparedness and response.
https://apps.who.int/iris/handle/10665/259893.
3.
World Health Organization. Pandemic influenza severity assessment (PISA): a WHO
guide to assess the severity of influenza in seasonal epidemics and pandemics.
https://apps.who.int/iris/handle/10665/259392.
4.
Biggerstaff, M., Cauchemez, S., Reed, C., Gambhir, M. & Finelli, L. Estimates of the
reproduction number for seasonal, pandemic, and zoonotic influenza: A systematic
review of the literature. BMC Infect Dis 14, 1–20 (2014).
5.
Billah, M. A., Miah, M. M. & Khan, M. N. Reproductive number of coronavirus: A
systematic review and meta-analysis based on global level evidence. PLoS One 15,
e0242128 (2020).
6.
Yang, W. & Shaman, J. L. COVID-19 pandemic dynamics in South Africa and
epidemiological characteristics of three variants of concern (Beta, Delta, and
Omicron). Elife 11, (2022).
7.
Tokars, J. I., Olsen, S. J. & Reed, C. Seasonal Incidence of Symptomatic Influenza in
the United States. Clin Infect Dis 66, 1511 (2018).
8.
Ferguson, N. M. et al. Strategies for mitigating an influenza pandemic. Nature 2006
442:7101 442, 448–452 (2006).
9.
Tokars, J. I. et al. Waning of Measured Influenza Vaccine Effectiveness Over Time:
The Potential Contribution of Leaky Vaccine Effect. Clinical Infectious Diseases 71,
e633–e641 (2020).
10.
Ray, G. T. et al. Intraseason Waning of Influenza Vaccine Effectiveness. Clin Infect
Dis 68, 1623-1630 (2019)
11.
Guarnaccia, T. et al. Antigenic Drift of the Pandemic 2009 A(H1N1) Influenza Virus
in a Ferret Model. PLoS Pathog 9, e1003354 (2013).
12.
Planas, D. et al. Reduced sensitivity of SARS-CoV-2 variant Delta to antibody
neutralization. Nature 596, 276–280 (2021).
13.
Harvey, W. T. et al. SARS-CoV-2 variants, spike mutations and immune escape. Nat
Rev Microbiol 19, 409–424 (2021).
14.
Planas, D. et al. Considerable escape of SARS-CoV-2 Omicron to antibody
neutralization. Nature 602, 671–675 (2022).
13
1.
World Health Organization. International Health Regulations (2005) Third Edition.
https://www.who.int/publications/i/item/9789241580496.
2.
World Health Organization. Pandemic influenza risk management: a WHO guide to
inform and harmonize national and international pandemic preparedness and response.
https://apps.who.int/iris/handle/10665/259893.
3.
World Health Organization. Pandemic influenza severity assessment (PISA): a WHO
guide to assess the severity of influenza in seasonal epidemics and pandemics.
https://apps.who.int/iris/handle/10665/259392.
4.
Biggerstaff, M., Cauchemez, S., Reed, C., Gambhir, M. & Finelli, L. Estimates of the
reproduction number for seasonal, pandemic, and zoonotic influenza: A systematic
review of the literature. BMC Infect Dis 14, 1–20 (2014).
5.
Billah, M. A., Miah, M. M. & Khan, M. N. Reproductive number of coronavirus: A
systematic review and meta-analysis based on global level evidence. PLoS One 15,
e0242128 (2020).
6.
Yang, W. & Shaman, J. L. COVID-19 pandemic dynamics in South Africa and
epidemiological characteristics of three variants of concern (Beta, Delta, and
Omicron). Elife 11, (2022).
7.
Tokars, J. I., Olsen, S. J. & Reed, C. Seasonal Incidence of Symptomatic Influenza in
the United States. Clin Infect Dis 66, 1511 (2018).
8.
Ferguson, N. M. et al. Strategies for mitigating an influenza pandemic. Nature 2006
442:7101 442, 448–452 (2006).
9.
Tokars, J. I. et al. Waning of Measured Influenza Vaccine Effectiveness Over Time:
The Potential Contribution of Leaky Vaccine Effect. Clinical Infectious Diseases 71,
e633–e641 (2020).
10.
Ray, G. T. et al. Intraseason Waning of Influenza Vaccine Effectiveness. Clin Infect
Dis 68, 1623-1630 (2019)
11.
Guarnaccia, T. et al. Antigenic Drift of the Pandemic 2009 A(H1N1) Influenza Virus
in a Ferret Model. PLoS Pathog 9, e1003354 (2013).
12.
Planas, D. et al. Reduced sensitivity of SARS-CoV-2 variant Delta to antibody
neutralization. Nature 596, 276–280 (2021).
13.
Harvey, W. T. et al. SARS-CoV-2 variants, spike mutations and immune escape. Nat
Rev Microbiol 19, 409–424 (2021).
14.
Planas, D. et al. Considerable escape of SARS-CoV-2 Omicron to antibody
neutralization. Nature 602, 671–675 (2022).
13